title: Effects of serotonergic medications on locomotor performance in humans with incomplete spinal cord injury.
abstract: Incomplete spinal cord injury (iSCI) often results in significant motor impairments that lead to decreased functional mobility. Loss of descending serotonergic (5HT) input to spinal circuits is thought to contribute to motor impairments, with enhanced motor function demonstrated through augmentation of 5HT signaling. However, the presence of spastic motor behaviors in SCI is attributed, in part, to changes in spinal 5HT receptors that augment their activity in the absence of 5HT, although data demonstrating motor effects of 5HT agents that deactivate these receptors are conflicting. The effects of enhancement or depression of 5HT signaling on locomotor function have not been thoroughly evaluated in human iSCI. Therefore, the aim of the current study was to investigate acute effects of 5HT medications on locomotion in 10 subjects with chronic (>1 year) iSCI. Peak overground and treadmill locomotor performance, including measures of gait kinematics, electromyographic (EMG) activity, and oxygen consumption, were assessed before and after single-dose administration of either a selective serotonin reuptake inhibitor (SSRI) or a 5HT antagonist using a double-blinded, randomized, cross-over design. Results indicate that neither medication led to improvements in locomotion, with a significant decrease in peak overground gait speed observed after 5HT antagonists (from 0.8±0.1 to 0.7±0.1 m/s; p=0.01). Additionally, 5-HT medications had differential effects on EMG activity, with 5HT antagonists decreasing extensor activity and SSRIs increasing flexor activity. Our data therefore suggest that acute manipulation of 5HT signaling, despite changes in muscle activity, does not improve locomotor performance after iSCI.
authors.affiliation: 1 Northwestern University Interdepartmental Neuroscience Program , Northwestern University, Chicago, Illinois.
authors.forename: Kristan A
authors.initials: KA
authors.lastname: Leech
authors.forename: Catherine R
authors.initials: CR
authors.lastname: Kinnaird
authors.forename: T George
authors.initials: TG
authors.lastname: Hornby
mesh_terms: D000328:Adult; D015283:Citalopram / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects*; D020127:Recovery of Function / Q000187:drug effects*; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013119:Spinal Cord Injuries / Q000188:drug therapy*
chemical_list: D015283:Citalopram; D003533:Cyproheptadine; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors
keywords: locomotor function; neurotransmitters; rehabilitation; spinal cord injury
references.citation: Am J Phys Med Rehabil. 1989 Feb;68(1):32-6
references.pmid: 2917056
references.citation: Arch Phys Med Rehabil. 2006 Sep;87(9):1218-22
references.pmid: 16935058
references.citation: Brain. 2004 Oct;127(Pt 10):2247-58
references.pmid: 15342360
references.citation: Arch Phys Med Rehabil. 2005 Apr;86(4):672-80
references.pmid: 15827916
references.citation: Neuroimage. 2005 Aug 15;27(2):299-313
references.pmid: 15950492
references.citation: J Biomech. 2009 Jun 19;42(9):1282-7
references.pmid: 19394023
references.citation: Muscle Nerve Suppl. 1997;6:S92-120
references.pmid: 9826984
references.citation: J Biol Chem. 2012 Nov 23;287(48):40224-31
references.pmid: 23038269
references.citation: Phys Ther. 2002 Jul;82(7):707-15
references.pmid: 12088467
references.citation: J Neurol Phys Ther. 2005 Sep;29(3):127-37
references.pmid: 16398945
references.citation: Phys Ther. 1975 Apr;55(4):355-9
references.pmid: 1118465
references.citation: Arch Phys Med Rehabil. 1999 Mar;80(3):339-42
references.pmid: 10084445
references.citation: J Spinal Cord Med. 2009;32(1):63-71
references.pmid: 19264051
references.citation: J Neurol. 1986 Oct;233(5):311-4
references.pmid: 3772412
references.citation: J Physiol. 2000 Oct 15;528 Pt 2:389-404
references.pmid: 11034628
references.citation: Brain Res. 1990 Apr 23;514(1):55-67
references.pmid: 2357531
references.citation: J Neurophysiol. 2013 Apr;109(8):2056-63
references.pmid: 23365181
references.citation: J Neurophysiol. 2010 Feb;103(2):844-57
references.pmid: 20007501
references.citation: Spinal Cord. 2001 Dec;39(12):654-6
references.pmid: 11781863
references.citation: Arch Phys Med Rehabil. 1996 Jul;77(7):635-8
references.pmid: 8669987
references.citation: Arch Phys Med Rehabil. 2005 Jan;86(1):52-9
references.pmid: 15640989
references.citation: Phys Ther. 1987 Feb;67(2):206-7
references.pmid: 3809245
references.citation: J Neurol Sci. 1990 Dec;100(1-2):85-93
references.pmid: 2089144
references.citation: J Neurol Neurosurg Psychiatry. 1990 Sep;53(9):754-63
references.pmid: 2246657
references.citation: Neurorehabil Neural Repair. 2007 Jan-Feb;21(1):25-35
references.pmid: 17172551
references.citation: Stroke. 1996 Jul;27(7):1211-4
references.pmid: 8685930
references.citation: Spine (Phila Pa 1976). 2008 Feb 1;33(3):259-64
references.pmid: 18303457
references.citation: J Vis Exp. 2011 Apr 18;(50):
references.pmid: 21525848
references.citation: Neurology. 2012 Feb 21;78(8):578-84
references.pmid: 22351795
references.citation: Curr Top Med Chem. 2002 Aug;2(8):795-816
references.pmid: 12171572
references.citation: Neuroimage. 2002 Jan;15(1):26-36
references.pmid: 11771971
references.citation: J Toxicol Clin Toxicol. 2004;42(1):79-83
references.pmid: 15083941
references.citation: Ann Neurol. 2001 Dec;50(6):718-29
references.pmid: 11761469
references.citation: Phys Ther. 2009 Aug;89(8):829-39
references.pmid: 19520734
references.citation: Eur J Neurosci. 2002 Aug;16(3):467-76
references.pmid: 12193190
references.citation: Spinal Cord. 2005 Oct;43(10):577-86
references.pmid: 15838527
references.citation: J Neurophysiol. 2010 Dec;104(6):2975-84
references.pmid: 20861436
references.citation: Phys Ther. 2010 Feb;90(2):224-35
references.pmid: 20022997
references.citation: J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):93-6
references.pmid: 11413270
references.citation: Spine (Phila Pa 1976). 1996 Mar 1;21(5):614-9
references.pmid: 8852318
references.citation: Arch Phys Med Rehabil. 1996 Jan;77(1):35-9
references.pmid: 8554471
references.citation: Lancet Neurol. 2011 Feb;10(2):123-30
references.pmid: 21216670
references.citation: Arch Phys Med Rehabil. 1989 Feb;70(2):144-55
references.pmid: 2644919
references.citation: J Neurotrauma. 2012 Mar 20;29(5):865-79
references.pmid: 22142289
references.citation: Nat Med. 2010 Jun;16(6):694-700
references.pmid: 20512126
references.citation: Spinal Cord. 2004 Mar;42(3):156-62
references.pmid: 15001980
references.citation: Electroencephalogr Clin Neurophysiol. 1989 Sep;73(3):233-44
references.pmid: 2475328
references.citation: Neurorehabil Neural Repair. 2008 May-Jun;22(3):311-4
references.pmid: 18219053
references.citation: J Spinal Cord Med. 2000 Winter;23(4):289-316
references.pmid: 17536300
references.citation: J Neurol Neurosurg Psychiatry. 1982 Oct;45(10):923-6
references.pmid: 7143011
references.citation: Top Stroke Rehabil. 2011 Jul-Aug;18(4):293-307
references.pmid: 21914594
references.citation: Eura Medicophys. 2006 Mar;42(1):5-15
references.pmid: 16565680
references.citation: Arch Phys Med Rehabil. 2003 Aug;84(8):1194-9
references.pmid: 12917859
references.citation: J Neurosci. 2005 Dec 14;25(50):11738-47
references.pmid: 16354932
references.citation: Annu Rev Neurosci. 2004;27:145-67
references.pmid: 15217329
references.citation: Spinal Cord. 1998 Oct;36(10):699-715
references.pmid: 9800274
references.citation: J Neurophysiol. 2007 Feb;97(2):1236-46
references.pmid: 17079337
references.citation: J Neurotrauma. 2013 Mar 15;30(6):498-502
references.pmid: 22994901
references.citation: J Am Paraplegia Soc. 1987 Jul-Oct;10(2):35-9
references.pmid: 3450779
references.citation: Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S146-60
references.pmid: 11805622